Browse by Glasgow Author (original) (raw)
Jump to: 2025 | 2022 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2005 | 2004 | 2003 | 2002 | 2001
Number of items: 24.
2025
Estcourt, L. J. et al. (2025)Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial. Lancet Haematology, 12(1), e14-e22. (doi: 10.1016/S2352-3026(24)00317-X) (PMID:39642900)
2022
Loke, J. et al. (2022)Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with highârisk acute myeloid leukaemia ineligible for intensive chemotherapy. British Journal of Haematology, 196(2), pp. 368-373. (doi: 10.1111/bjh.17823) (PMID:34490623)
2013
Gallipoli, P. et al. (2013)Safety and efficacy of pulsed imatinib with or without G-CSFversuscontinuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up. British Journal of Haematology, 163(5), pp. 674-676. (doi: 10.1111/bjh.12532)
2012
Ahmad, Faheem A. and Drummond, Mark W.(2012)Reversible nicorandil induced perianal ulceration in acute myeloid leukemia. Leukemia and Lymphoma, 53(2), pp. 334-335. (doi: 10.3109/10428194.2011.610016) (PMID:21823834)
2011
Gallipoli, Paolo, Shepherd, Pat, Irvine, David, Drummond, Mark and Holyoake, Tessa(2011)Restricted access to second generation tyrosine kinase inhibitors in the UK could result in suboptimal treatment for almost half of chronic myeloid leukaemia patients: results from a West of Scotland and Lothian population study. British Journal of Haematology, 155(1), pp. 128-130. (doi: 10.1111/j.1365-2141.2011.08653.x)
2010
Milojkovic, D. et al. (2010)Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia. Haematologica, 95(2), pp. 224-231. (doi: 10.3324/haematol.2009.012781) (PMID:19833633) (PMCID:PMC2817024)
Todd, M., Welsh, J. and Drummond, M.W.(2010)Primary Lymphedema and Acute Leukemia - Is There A Link? Lymphology, 43(1), pp. 42-44.
2009
Murray, Eleanor, Magill, Louise J., Nunn, Kieran P. and Drummond, Mark W.(2009)Furtive bleeding. American Journal of Medicine, 122(8), pp. 729-731. (doi: 10.1016/j.amjmed.2009.04.008)
Drummond, M.W. et al. (2009)A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response. Leukemia, 23(6), pp. 1199-1201. (doi: 10.1038/leu.2009.43)
Foo, J., Drummond, M.W., Clarkson, B., Holyoake, T. and Michor, F.(2009)Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib. PLoS Computational Biology, 5(9), e1000503. (doi: 10.1371/journal.pcbi.1000503) (PMID:19749982) (PMCID:PMC2730033)
2008
Shepherd, P, Dhanapala, C, Maguire, C, White, J, Drummond, MW, Holyoake, T and Johnson, PRE(2008)Successful use of national cancer registry data to monitor the effective use of imatinib for treating chronic myeloid leukaemia. Scottish Medical Journal, 53(3), pp. 8-12.
2007
Drummond, MW, Balabanov, S, Holyoake, TL and Brummendorf, TH(2007)Concise review: Telomere biology in normal and leukemic hematopoietic stem cells. Stem Cells, 25(8), pp. 1853-1861. (doi: 10.1634/stemcells.2007-0057)
2005
Drummond, M.W., Hoare, S.F., Monaghan, A., Graham, S.M., Alcorn, M.J., Keith, W.N. 
ORCID: https://orcid.org/0000-0001-7862-3580 and Holyoake, T.L.(2005)Dysregulated expression of the major telomerase components in leukaemic stem cells. Leukemia, 19(3), pp. 381-389. (doi: 10.1038/sj.leu.2403616)
Reed, S. et al. (2005)Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. American Heart Journal, 149(3), pp. 434-443.
2004
Drummond, MW, Lennard, A, Brummendorf, TH and Holyoake, TL(2004)Telomere shortening correlates with prognostic score at diagnosis and proceeds rapidly during progression of chronic myeloid leukemia. Leukemia and Lymphoma, 45(9), pp. 1775-1781. (doi: 10.1080/10428190410001693542)
2003
Drummond, MW, Marin, D, Clark, RE, Byrne, JL, Holyoake, TL and Lennard, A(2003)Mobilization of Ph chromosome-negative peripheral blood stem cells in chronic myeloid leukaemia patients with imatinib mesylate-induced complete cytogenetic remission. British Journal of Haematology, 123(3), pp. 479-483. (doi: 10.1046/j.1365-2141.2003.04599.x)
Drummond, MW and Holyoake, T(2003)Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Cancer, 98(8), pp. 1776-1777. (doi: 10.1002/cncr.11715)
Drummond, A, Micallef-Eynaud, P, Douglas, WS, Murphy, JA, Hay, I, Holyoake, T and Drummond, MW(2003)A spectrum of skin reactions caused by the tyrosine kinase inhibitor imatinib mesylate (STI 571, Glivec (R)). British Journal of Haematology, 120(5), pp. 911-913. (doi: 10.1046/j.1365-2141.2003.04151_4.x)
Drummond, MW, Lush, CJ, Vickers, MA, Reid, FM, Kaeda, J and Holyoake, T(2003)Imatinib mesylate-induced molecular remission of Philadelphia chromosome-positive myelodysplastic syndrome. Leukemia, 17(2), pp. 463-465. (doi: 10.1038/sj.leu.2402814)
Asplund, K, Ashburner, S, Cargill, K, Hux, M, Lees, K and Drummond, MW(2003)Health care resource use and stroke outcome - Multinational comparisons within the GAIN International trial. International Journal of Technology Assessment in Health Care, 19, pp. 267-277.
Craig, D. et al. (2003)New BMJ policy on economic evaluations. Economic evaluations should be judged on economic merit. British Medical Journal, 326(7386), p. 445.
2002
Drummond, MW, Hendry, LM, Maher, E and Holyoake, Tessa(2002)BCR-ABL fish monitoring of CML: A survey of current UK practice. British Journal of Haematology, 119(1), pp. 272-273. (doi: 10.1046/j.1365-2141.2002.38802.x)
Holyoake, T, Jiang, X, Drummond, MW, Eaves, AC and Eaves, CJ(2002)Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia. Leukemia, 16(4), pp. 549-558. (doi: 10.1038/sj/leu/2402444)
2001
Drummond, MW and Holyoake, TL(2001)Tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia: so far so good? Blood Reviews, 15(2), pp. 85-95. (doi: 10.1054/blre.2001.0152)
This list was generated on Tue Feb 17 08:04:17 2026 GMT.